The differentiation of antigen-specific cytotoxic T lymphocytes during T-cell engager therapy is associated with reduced nuclear factor of activated T cells transcriptional activity and activation of the WNT signaling pathway. The resulting molecular profile supports enhanced T-cell fitness and mitigates exhaustion. See the article by Bariana et al.